Global markets are cautiously optimistic about a potential US-Iran agreement easing geopolitical risks and crude oil volatility. However, I...

India’s REIT and InvIT market could attract an additional Rs 11.6 trillion in investments by 2030, taking total assets under management bey...

The Reserve Bank of India has opened direct equity investment in listed firms to all foreign individuals, expanding beyond NRIs and OCIs. T...

Indian equities surged nearly 1% as bulls charged through Dalal Street, driven by an Iran-US peace framework and sliding oil prices. The Se...

A US-Iran peace framework has sparked a sharp rally in Indian markets, sending crude oil prices lower, strengthening the rupee and promptin...

The Indian Rupee strengthened significantly against the US Dollar on Monday. This surge followed the announcement of a peace deal between t...

SpaceX's massive IPO is making waves globally. However, Indian market experts believe this will not directly impact upcoming listings of Ji...

Indian artificial intelligence companies are increasingly securing funding from the United States. Investors are drawn to promising returns...

Foreign investors continue to sell Indian shares. They have withdrawn over Rs 62,853 crore in early June. This follows significant outflows...

India's wealthy investors are now considering global markets. Wealth managers at the ET Alpha Wealth Summit confirmed this shift. However, ...

In a remarkable turnaround, Indian stock markets soared on Friday, with major indices climbing over two percent, their highest gains in the...

Manish Banthia, CIO-Fixed Income at ICICI Prudential AMC, who correctly predicted the gold rally in 2023, now sees little value in adding f...

Domestic benchmarks Nifty 50 and Sensex are down about 11% and 13% so far in 2026, respectively, after fears of AI-led disruption tanked th...

India's IPO arena is poised for dynamic growth, with a wave of businesses on the brink of launching their public shares, fueled by an incre...

Citi Research lowered its Nifty target due to rising earnings risks linked to geopolitical tensions and other macro concerns. However, it r...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Domestic institutional investors (DIIs) have remained strong buyers of Indian equities in 2026, with net purchases crossing Rs 4.16 lakh cr...